NasdaqCM - Delayed Quote USD
Sanara MedTech Inc. (SMTI)
At close: November 1 at 4:00 PM EDT
After hours: November 1 at 4:02 PM EDT
Research Analysis
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 1 | 1 | 1 | 1 |
Avg. Estimate | -0.62 | -0.7 | -2.03 | -1.17 |
Low Estimate | -0.62 | -0.7 | -2.03 | -1.17 |
High Estimate | -0.62 | -0.7 | -2.03 | -1.17 |
Year Ago EPS | -0.13 | -0.03 | -0.52 | -2.03 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 1 | 1 | 1 | 1 |
Avg. Estimate | 20.7M | 21.5M | 80.9M | 96.2M |
Low Estimate | 20.7M | 21.5M | 80.9M | 96.2M |
High Estimate | 20.7M | 21.5M | 80.9M | 96.2M |
Year Ago Sales | -- | 17.69M | 64.99M | 80.9M |
Sales Growth (year/est) | -- | 21.50% | 24.50% | 18.90% |
Earnings History
CURRENCY IN USD | 9/30/2023 | 12/31/2023 | 3/31/2024 | 6/30/2024 |
---|---|---|---|---|
EPS Est. | 0 | -0.13 | -0.07 | -0.21 |
EPS Actual | -0.13 | -0.03 | -0.21 | -0.41 |
Difference | -0.13 | 0.1 | -0.14 | -0.2 |
Surprise % | -- | 76.90% | -200.00% | -95.20% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | -0.62 | -0.7 | -2.03 | -1.17 |
7 Days Ago | -0.62 | -0.7 | -2.03 | -1.17 |
30 Days Ago | -0.62 | -0.7 | -2.03 | -1.17 |
60 Days Ago | -0.62 | -0.7 | -2.03 | -1.17 |
90 Days Ago | -0.2 | -0.14 | -0.79 | -0.11 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
CURRENCY IN USD | SMTI | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | -376.90% | -- | -- | 5.10% |
Next Qtr. | -2,233.30% | -- | -- | 11.80% |
Current Year | -290.40% | -- | -- | 2.10% |
Next Year | 42.40% | -- | -- | 12.30% |
Next 5 Years (per annum) | -- | -- | -- | 11.68% |
Past 5 Years (per annum) | -- | -- | -- | -- |
Upgrades & Downgrades
Reiterates | Cantor Fitzgerald: Overweight to Overweight | 5/15/2024 |
Maintains | Cantor Fitzgerald: Overweight to Overweight | 3/27/2024 |
Reiterates | Cantor Fitzgerald: Overweight to Overweight | 2/6/2024 |
Maintains | Cantor Fitzgerald: Overweight to Overweight | 11/15/2023 |
Reiterates | Cantor Fitzgerald: Overweight to Overweight | 9/26/2023 |
Reiterates | Cantor Fitzgerald: Overweight to Overweight | 8/22/2023 |
Related Tickers
INFU InfuSystem Holdings, Inc.
6.39
+3.23%
NEPH Nephros, Inc.
1.4589
+0.61%
UTMD Utah Medical Products, Inc.
64.09
+1.12%
POLYMED.NS Poly Medicure Limited
3,128.90
+8.86%
NXGL NEXGEL, Inc.
2.7800
-3.47%
AZTA Azenta, Inc.
41.22
+0.32%
AKYA Akoya Biosciences, Inc.
2.7300
-3.02%
LMAT LeMaitre Vascular, Inc.
94.88
+7.34%
TFX Teleflex Incorporated
211.21
+5.05%
MMSI Merit Medical Systems, Inc.
98.80
+0.14%